• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[涎腺导管癌]

[Salivary duct carcinoma].

作者信息

Hungermann D, Roeser K, Buerger H, Jäkel T, Löning T, Herbst H

机构信息

Gerhard-Domagk-Institut für Pathologie, Universitätsklinikum Münster.

出版信息

Pathologe. 2005 Sep;26(5):353-8. doi: 10.1007/s00292-005-0775-0.

DOI:10.1007/s00292-005-0775-0
PMID:16041504
Abstract

This tutorial focuses on salivary duct carcinoma (SDC), a rare, high grade neoplasm mainly of major salivary glands. The clinical course of these tumors is characterised by extended local disease, early distant metastasis, and poor outcome. The morphology of SDC is reminiscent of breast ductal carcinomas and may occasionally cause diagnostic problems. In spite of mimicry with ductal carcinoma in situ of the breast and an in situ component, that is evident in most tumors by immunohistology with antibodies directed against high molecular weight cytokeratins (Ck), SDC is always an invasive carcinoma. By immunohistology, most tumors show reactivity with antibodies directed against Ck 7, Ck 8/18 and Ck 19 whereas a morphologically indistinguishable subgroup expresses Ck 5/6 in tumor cells in addition to residual basal epithelia. Carcinoembryonic antigen, GCDFP-15 and androgen receptor are other helpful markers in routine diagnosis of SDC. Prostate-specific antigen is detectable in some cases. Abnormal p53 expression seems to indicate an adverse prognosis. Expression of c-erbB2, the over-expression of which is associated with a poor prognosis, may form the basis for a targeted therapeutic approach for selected cases of SDC.

摘要

本教程聚焦于涎腺导管癌(SDC),这是一种主要发生于大涎腺的罕见的高级别肿瘤。这些肿瘤的临床病程特点为局部病变广泛、早期远处转移以及预后不良。SDC的形态学类似于乳腺导管癌,偶尔可能会导致诊断难题。尽管与乳腺导管原位癌及原位成分存在相似之处,大多数肿瘤通过针对高分子量细胞角蛋白(Ck)的抗体进行免疫组织化学检测可明确显示这一点,但SDC始终是浸润性癌。通过免疫组织化学检测,大多数肿瘤对针对Ck 7、Ck 8/18和Ck 19的抗体呈阳性反应,而在形态上难以区分的一个亚组除残留的基底上皮外,肿瘤细胞中还表达Ck 5/6。癌胚抗原、GCDFP - 15和雄激素受体是SDC常规诊断中的其他有用标志物。在某些病例中可检测到前列腺特异性抗原。p53异常表达似乎提示预后不良。c - erbB2的表达,其过度表达与预后不良相关,可能为部分SDC病例的靶向治疗方法奠定基础。

相似文献

1
[Salivary duct carcinoma].[涎腺导管癌]
Pathologe. 2005 Sep;26(5):353-8. doi: 10.1007/s00292-005-0775-0.
2
[Salivary duct carcinomas comprise phenotypically and genotypically diverse high grade neoplasms].涎腺导管癌由表型和基因型多样的高级别肿瘤组成。
Verh Dtsch Ges Pathol. 2006;90:168-76.
3
Salivary Duct Carcinoma: An Update on Morphologic Mimics and Diagnostic Use of Androgen Receptor Immunohistochemistry.涎腺导管癌:形态学模仿物及雄激素受体免疫组化诊断应用的最新进展
Head Neck Pathol. 2017 Sep;11(3):288-294. doi: 10.1007/s12105-017-0798-x. Epub 2017 Mar 20.
4
Genomic alteration in rare subtype of sarcomatoid salivary duct carcinoma.罕见肉瘤样唾液腺癌亚型的基因组改变。
Pathol Res Pract. 2021 Dec;228:153678. doi: 10.1016/j.prp.2021.153678. Epub 2021 Oct 29.
5
Salivary duct carcinoma with rhabdoid features: a salivary counterpart of pleomorphic lobular carcinoma of the breast.具有横纹肌样特征的涎腺导管癌:乳腺多形性小叶癌的涎腺对应物。
Histopathology. 2017 Jan;70(2):164-173. doi: 10.1111/his.12987. Epub 2016 Jun 8.
6
Salivary duct carcinomas can be classified into luminal androgen receptor-positive, HER2 and basal-like phenotypes.唾液腺癌可分为腔面雄激素受体阳性、HER2 和基底样表型。
Histopathology. 2012 Oct;61(4):629-43. doi: 10.1111/j.1365-2559.2012.04252.x.
7
Androgen receptor immunohistochemistry in salivary duct carcinoma: a retrospective study of 188 cases focusing on tumoral heterogeneity and temporal concordance.唾液腺癌中雄激素受体免疫组化:聚焦肿瘤异质性和时间一致性的 188 例回顾性研究。
Hum Pathol. 2019 Nov;93:30-36. doi: 10.1016/j.humpath.2019.08.007. Epub 2019 Aug 17.
8
Biomarker immunoprofile and molecular characteristics in salivary duct carcinoma: clinicopathological and prognostic implications.唾液腺癌的免疫组化标志物和分子特征:临床病理和预后意义。
Hum Pathol. 2019 Nov;93:37-47. doi: 10.1016/j.humpath.2019.08.009. Epub 2019 Aug 19.
9
Clinical and immunohistologic typing of salivary duct carcinoma: a report of 50 cases.涎腺导管癌的临床与免疫组织化学分型:50例报告
Cancer. 2005 Jun 15;103(12):2526-33. doi: 10.1002/cncr.21116.
10
Expression pattern of androgen receptor and AR-V7 in androgen-deprivation therapy-naïve salivary duct carcinomas.雄激素受体和 AR-V7 在雄激素剥夺治疗初治涎腺癌中的表达模式。
Hum Pathol. 2019 Feb;84:173-182. doi: 10.1016/j.humpath.2018.09.009. Epub 2018 Sep 26.

引用本文的文献

1
[Female prostate cancer?].[女性前列腺癌?]
Pathologe. 2017 Sep;38(5):448-450. doi: 10.1007/s00292-017-0322-9.
2
Salivary Duct Carcinoma: An Update on Morphologic Mimics and Diagnostic Use of Androgen Receptor Immunohistochemistry.涎腺导管癌:形态学模仿物及雄激素受体免疫组化诊断应用的最新进展
Head Neck Pathol. 2017 Sep;11(3):288-294. doi: 10.1007/s12105-017-0798-x. Epub 2017 Mar 20.
3
Salivary duct carcinoma: new developments--morphological variants including pure in situ high grade lesions; proposed molecular classification.

本文引用的文献

1
Mucin-rich variant of salivary duct carcinoma: a clinicopathologic and immunohistochemical study of four cases.涎腺导管癌富含黏液变体:4例临床病理及免疫组化研究
Am J Surg Pathol. 2003 Aug;27(8):1070-9. doi: 10.1097/00000478-200308000-00004.
2
Intraoral salivary duct carcinoma: a report of 5 cases.口腔内涎腺导管癌:5例报告
J Oral Maxillofac Surg. 2003 Jan;61(1):126-31. doi: 10.1053/joms.2003.50021.
3
Salivary duct carcinoma--a highly aggressive salivary gland tumor with HER-2/neu oncoprotein overexpression.涎腺导管癌——一种具有HER-2/neu癌蛋白过表达的高侵袭性涎腺肿瘤。
涎腺导管癌:新进展——包括纯原位高级别病变在内的形态学变异;提议的分子分类
Head Neck Pathol. 2013 Jul;7 Suppl 1(Suppl 1):S48-58. doi: 10.1007/s12105-013-0456-x. Epub 2013 Jul 3.
4
[Primary ductal adenocarcinoma near the orbit].眼眶附近原发性导管腺癌
Pathologe. 2010 Jul;31(4):279-82. doi: 10.1007/s00292-010-1291-4.
Pathol Res Pract. 2001;197(9):621-6. doi: 10.1078/0344-0338-00136.
4
Molecular and biomarker analyses of salivary duct carcinomas: comparison with mammary duct carcinoma.涎腺导管癌的分子和生物标志物分析:与乳腺导管癌的比较。
Int J Oncol. 2001 Oct;19(4):865-71. doi: 10.3892/ijo.19.4.865.
5
[About the prognostic value of Her-2 gene-amplification and cell-proliferation in salivary duct carcinoma of the major salivary glands - a pilot-study].[关于Her-2基因扩增及细胞增殖在大唾液腺涎腺导管癌中的预后价值——一项初步研究]
Laryngorhinootologie. 2001 Sep;80(9):525-9. doi: 10.1055/s-2001-17088.
6
Expression of androgen receptor, gross cystic disease fluid protein, and CD44 in salivary duct carcinoma.雄激素受体、巨大囊肿病液体蛋白及CD44在涎腺导管癌中的表达
Mod Pathol. 1998 Nov;11(11):1033-8.
7
Salivary duct carcinoma: clinicopathological and immunohistochemical studies.
J Craniomaxillofac Surg. 1997 Dec;25(6):328-34. doi: 10.1016/s1010-5182(97)80035-2.
8
Homologous carcinomas of the breasts, skin, and salivary glands. A histologic and immunohistochemical comparison of ductal mammary carcinoma, ductal sweat gland carcinoma, and salivary duct carcinoma.乳腺、皮肤和唾液腺的同源性癌。乳腺导管癌、汗腺导管癌和唾液腺导管癌的组织学及免疫组化比较。
Am J Clin Pathol. 1998 Jan;109(1):75-84. doi: 10.1093/ajcp/109.1.75.
9
Salivary duct carcinoma. Clinicopathologic and immunohistochemical review of 26 cases.涎腺导管癌。26例临床病理及免疫组化回顾性研究。
Cancer. 1996 Jan 15;77(2):223-30. doi: 10.1002/(SICI)1097-0142(19960115)77:2<223::AID-CNCR1>3.0.CO;2-N.
10
Intraoral salivary duct carcinoma: a clinicopathological study of four cases and review of the literature.口腔内涎腺导管癌:4例临床病理研究及文献复习
Ann Dent. 1995 Summer-Fall;54(1-2):36-40.